Shanda Asset Management Holdings LTD Bio N Tech Se Transaction History
Shanda Asset Management Holdings LTD
- $1.77 Billion
- Q3 2024
A detailed history of Shanda Asset Management Holdings LTD transactions in Bio N Tech Se stock. As of the latest transaction made, Shanda Asset Management Holdings LTD holds 64,800 shares of BNTX stock, worth $7.96 Million. This represents 1.84% of its overall portfolio holdings.
Number of Shares
64,800Holding current value
$7.96 Million% of portfolio
1.84%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BNTX
# of Institutions
356Shares Held
38.3MCall Options Held
2.45MPut Options Held
2.29M-
Baillie Gifford & CO8.31MShares$1.02 Billion0.75% of portfolio
-
Primecap Management CO Pasadena, CA4.52MShares$555 Million0.4% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.36MShares$536 Million2.05% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$233 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$222 Million0.88% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $29.8B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...